166 related articles for article (PubMed ID: 33339421)
1. Immune Checkpoint Inhibitors with or without Radiotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis.
Kim DY; Kim PH; Suh CH; Kim KW; Kim HS
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33339421
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitor with or without Radiotherapy in Melanoma Patients with Brain Metastases: A Systematic Review and Meta-Analysis.
Kim PH; Suh CH; Kim HS; Kim KW; Kim DY; Lee EQ; Aizer AA; Guenette JP; Huang RY
Korean J Radiol; 2021 Apr; 22(4):584-595. PubMed ID: 33289357
[TBL] [Abstract][Full Text] [Related]
3. A cohort study of the efficacy and safety of immune checkpoint inhibitors plus anlotinib versus immune checkpoint inhibitors alone as the treatment of advanced non-small cell lung cancer in the real world.
Shi Y; Ji M; Jiang Y; Yin R; Wang Z; Li H; Wang S; He K; Ma Y; Wang Z; Lu J; Shi M; Shen B; Zhou G; Leong TL; Wang X; Chen C; Feng J
Transl Lung Cancer Res; 2022 Jun; 11(6):1051-1068. PubMed ID: 35832459
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis.
Xu S; Shukuya T; Tamura J; Shimamura S; Kurokawa K; Miura K; Miyawaki T; Hayakawa D; Asao T; Yamamoto K; Takahashi K
JTO Clin Res Rep; 2022 Apr; 3(4):100309. PubMed ID: 35434666
[TBL] [Abstract][Full Text] [Related]
5. Impact of Age on the Efficacy of Immune Checkpoint Inhibitor-Based Combination Therapy for Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Yan X; Tian X; Wu Z; Han W
Front Oncol; 2020; 10():1671. PubMed ID: 33072551
[No Abstract] [Full Text] [Related]
6. Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases.
Zhou J; Zhou F; Chu X; Zhao J; Wu Y; Zhao W; Xu C; Su C
Transl Lung Cancer Res; 2020 Apr; 9(2):316-324. PubMed ID: 32420071
[TBL] [Abstract][Full Text] [Related]
7. The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non-Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review.
Chai QQ; Du JY; Zhu J; Wu B
Front Pharmacol; 2019; 10():1260. PubMed ID: 31708783
[No Abstract] [Full Text] [Related]
8. Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: A systematic review.
Ma X; Zhang Y; Wang S; Wei H; Yu J
J Cancer; 2021; 12(5):1318-1333. PubMed ID: 33531977
[No Abstract] [Full Text] [Related]
9. Toxicity in combination immune checkpoint inhibitor and radiation therapy: A systematic review and meta-analysis.
Sha CM; Lehrer EJ; Hwang C; Trifiletti DM; Mackley HB; Drabick JJ; Zaorsky NG
Radiother Oncol; 2020 Oct; 151():141-148. PubMed ID: 32717359
[TBL] [Abstract][Full Text] [Related]
10. Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment.
El Rassy E; Botticella A; Kattan J; Le Péchoux C; Besse B; Hendriks L
Cancer Treat Rev; 2018 Jul; 68():69-79. PubMed ID: 29883857
[TBL] [Abstract][Full Text] [Related]
11. The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastases.
Zhou J; Wu Y; Xie M; Fang Y; Zhao J; Lee SY; Im Y; Ye L; Su C
Transl Lung Cancer Res; 2022 Apr; 11(4):656-669. PubMed ID: 35529783
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy.
Rounis K; Skribek M; Makrakis D; De Petris L; Agelaki S; Ekman S; Tsakonas G
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805335
[TBL] [Abstract][Full Text] [Related]
13. Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials.
El Osta B; Hu F; Sadek R; Chintalapally R; Tang SC
Crit Rev Oncol Hematol; 2017 Nov; 119():1-12. PubMed ID: 29065979
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis.
Peng M; Li X; Lei G; Weng YM; Hu MX; Song QB
Onco Targets Ther; 2018; 11():7369-7383. PubMed ID: 30425525
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.
Petrelli F; Lazzari C; Ardito R; Borgonovo K; Bulotta A; Conti B; Cabiddu M; Capitanio JF; Brighenti M; Ghilardi M; Gianni L; Barni S; Gregorc V
PLoS One; 2018; 13(7):e0201425. PubMed ID: 30052658
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.
Chicas-Sett R; Morales-Orue I; Castilla-Martinez J; Zafra-Martin J; Kannemann A; Blanco J; Lloret M; Lara PC
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052488
[No Abstract] [Full Text] [Related]
18. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
[TBL] [Abstract][Full Text] [Related]
19. Fatal Adverse Events Associated With Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Yu X; Zhang X; Yao T; Zhang Y; Zhang Y
Front Med (Lausanne); 2021; 8():627089. PubMed ID: 33659263
[No Abstract] [Full Text] [Related]
20. Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer.
Suwinski R
J Thorac Dis; 2021 May; 13(5):3315-3322. PubMed ID: 34164224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
